
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            c-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B0918AF33AB305B091002009D63C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="biolproc">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Biological Procedures Online">
<meta name="citation_title" content="c-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis">
<meta name="citation_author" content="Zhipeng Zhang">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Xinyi Lu">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Jianhui Tian">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Jiaxuan Li">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Shihui Liu">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Jiajun Liu">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Bin Luo">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Jialiang Yao">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Yao Liu">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Yanhong Wang">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Wang Yao">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Yun Yang">
<meta name="citation_author_institution" content="Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_author" content="Wenji Shangguan">
<meta name="citation_author_institution" content="Department of Traditional Chinese Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127 China">
<meta name="citation_author" content="Zujun Que">
<meta name="citation_author_institution" content="Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="27">
<meta name="citation_firstpage" content="32">
<meta name="citation_doi" content="10.1186/s12575-025-00295-0">
<meta name="citation_pmid" content="40836278">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/pdf/12575_2025_Article_295.pdf">
<meta name="description" content="Circulating tumor cells (CTCs) serve as the “seeds” of tumor metastasis, and the clustering of CTCs is critically associated with tumor metastasis and the mortality of lung cancer patients. Inhibiting the survival of CTC clusters represents a ...">
<meta name="og:title" content="c-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Circulating tumor cells (CTCs) serve as the “seeds” of tumor metastasis, and the clustering of CTCs is critically associated with tumor metastasis and the mortality of lung cancer patients. Inhibiting the survival of CTC clusters represents a ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366314">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12575-025-00295-0"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12575_2025_Article_295.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366314%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366314/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366314/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-biolproc.png" alt="Biological Procedures Online logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Biological Procedures Online" title="Link to Biological Procedures Online" shape="default" href="https://biologicalproceduresonline.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Biol Proced Online</button></div>. 2025 Aug 20;27:32. doi: <a href="https://doi.org/10.1186/s12575-025-00295-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12575-025-00295-0</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Biol%20Proced%20Online%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biol%20Proced%20Online%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Biol%20Proced%20Online%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Biol%20Proced%20Online%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>c-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Zhipeng Zhang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Zhipeng Zhang</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhipeng Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Xinyi Lu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Xinyi Lu</span></h3>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinyi Lu</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Jianhui Tian</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Jianhui Tian</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jianhui Tian</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jiaxuan Li</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jiaxuan Li</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiaxuan Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shihui Liu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shihui Liu</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shihui Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jiajun Liu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jiajun Liu</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiajun Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Bin Luo</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Bin Luo</span></h3>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bin Luo</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jialiang Yao</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jialiang Yao</span></h3>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jialiang Yao</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yao Liu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yao Liu</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yao Liu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yanhong Wang</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yanhong Wang</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanhong Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Wang Yao</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Wang Yao</span></h3>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yao%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wang Yao</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Yun Yang</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Yun Yang</span></h3>
<div class="p">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yun Yang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shangguan%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Wenji Shangguan</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Wenji Shangguan</span></h3>
<div class="p">
<sup>3</sup>Department of Traditional Chinese Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shangguan%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenji Shangguan</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Que%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Zujun Que</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Zujun Que</span></h3>
<div class="p">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Que%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zujun Que</span></a>
</div>
</div>
<sup>1,</sup><sup>✉,</sup><sup>#</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div id="Aff2">
<sup>2</sup>Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071 China </div>
<div id="Aff3">
<sup>3</sup>Department of Traditional Chinese Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 10; Accepted 2025 Jul 21; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366314  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40836278/" class="usa-link">40836278</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><hr class="headless">
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Circulating tumor cells (CTCs) serve as the “seeds” of tumor metastasis, and the clustering of CTCs is critically associated with tumor metastasis and the mortality of lung cancer patients. Inhibiting the survival of CTC clusters represents a pivotal strategy for anti-lung cancer metastasis therapy. This study is designed to explore the impact and underlying mechanism of lung cancer CTC clusters in mediating resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), thereby offering novel insights into anti-lung cancer metastasis treatment.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">Using the human lung adenocarcinoma CTC line CTC-TJH-01, we performed transcriptome analysis to identify differentially expressed genes. CCK-8, LDH, Calcein AM/EthD-1, and Annexin V-FITC/caspase-3 assays evaluated the effects of osimertinib, Tivantinib, or their combination on CTC-TJH-01 and A549 cell proliferation and apoptosis. RT-qPCR, western blot, and immunohistochemistry analyzed gene and protein expression. A lung metastasis mouse model was established by injecting CTC-TJH-01 clusters, with anatomical observation and H&amp;E staining for evaluation.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Our study demonstrated that CTC-TJH-01, A549, and H1975 cell clusters in suspension exhibited higher resistance to osimertinib compared to their adherent counterparts. Notably, the expression of the HGF gene was remarkably upregulated in CTC-TJH-01 cell clusters. Activation of the HGF/c-MET pathway was observed in CTC clusters, accompanied by a concurrent downregulation of EGFR protein expression. Significantly, the c-MET inhibitor Tivantinib, but not the HGF inhibitor SRI, effectively suppressed the survival of CTC-TJH-01 and A549 cell clusters. Moreover, Tivantinib, either as a single-agent or in combination with osimertinib, exerted a potent inhibitory effect on the in vivo metastasis of CTC-TJH-01 cell clusters.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">These findings indicate that CTC clusters contribute to resistance against EGFR-TKI treatment, and c-MET inhibitors hold promise as potential therapeutic agents for targeting CTC cluster survival to impede lung cancer metastasis.</p></section><section id="sec5"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/c8ac5b47f0e7/12575_2025_295_Figa_HTML.jpg" loading="lazy" id="MO1" height="473" width="669" alt="graphic file with name 12575_2025_295_Figa_HTML.jpg"></a></p></section><section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12575-025-00295-0.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Lung cancer, Circulating tumor cell clusters, Metastasis, Osimertinib resistance, C-MET inhibitor</p></section></section><section class="abstract" id="Abs2"><h2>Highlights</h2>
<p id="Par6">λ Lung cancer CTC clusters resist osimertinib, driving treatment resistance.​.</p>
<p id="Par7">λ HGF/c-MET signaling activates in CTC clusters, revealing a resistance mechanism.​.</p>
<p id="Par8">λ Tivantinib, a c-MET inhibitor, outperforms HGF inhibitor SRI in suppressing CTC cluster survival.​.</p>
<p id="Par9">λ Tivantinib plus osimertinib exerts additive inhibition on CTC cluster survival and metastasis, offering a potential anti-metastasis strategy.</p>
<section id="sec7"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12575-025-00295-0.</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par18">Lung cancer ranks first in both incidence and mortality among malignant tumors worldwide [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Surgical resection is the cornerstone of treatment for early-stage lung cancer patients; however, postoperative recurrence and metastasis remain the primary causes of mortality [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Adjuvant therapies, including chemotherapy and molecular targeted therapy, have been shown to significantly extend disease-free survival (DFS) and overall survival (OS) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Despite these advances, a substantial proportion of lung cancer patients experience disease progression within 1–3 years of adjuvant treatment, mainly attributed to treatment resistance [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Therefore, elucidating the mechanisms underlying lung cancer metastasis and disease progression during adjuvant therapy is essential for improving patient outcomes.</p>
<p id="Par19">
For non-small cell lung cancer (NSCLC) patients harboring EGFR gene mutations, EGFR-tyrosine kinase inhibitors (EGFR-TKIs) represent the standard-of-care treatment. Osimertinib, a third-generation EGFR-TKI, has demonstrated remarkable efficacy in prolonging DFS, progression-free survival (PFS), and OS for both early- and advanced-stage NSCLC patients with EGFR mutations [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Nevertheless, treatment resistance inevitably emerges, primarily due to EGFR gene mutations, activation of bypass signaling pathways, and phenotypic transformation of lung cancer cells. Among these, MET amplification or overexpression is a well-recognized mechanism of acquired resistance to osimertinib [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Combination therapy with MET inhibitors and EGFR-TKIs has shown promise in overcoming MET-mediated resistance [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], highlighting the importance of targeting alternative pathways.​</p>
<p id="Par20">Tumor metastasis is facilitated by the dissemination of tumor cells from the primary site to distant organs. Circulating tumor cells (CTCs), regarded as the “seeds” of primary tumor dissemination, play a critical role in this process. The quantity and state of CTCs are strongly correlated with metastasis and prognosis in early-stage lung cancer patients. Detectable CTCs, particularly CTC clusters, are associated with poorer DFS and OS, regardless of the treatment stage (pre-surgery, post-surgery, or adjuvant therapy) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. This is largely due to the enhanced metastatic potential of CTC clusters [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Strategies aiming to dissociate CTC clusters into single cells or inhibit their survival may offer new approaches for preventing lung cancer metastasis [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Additionally, CTCs serve as valuable biomarkers for predicting the response to osimertinib treatment and elucidating tumor characteristics and resistance mechanisms [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p>
<p id="Par21">
Despite the established significance of CTCs in lung cancer progression, the role of CTC clusters in mediating resistance to EGFR-TKIs remains unclear. In this study, using a human lung adenocarcinoma-derived CTC line (CTC-TJH-01) established in our laboratory, we aimed to investigate whether CTC clusters contribute to EGFR-TKI resistance and to elucidate the underlying molecular mechanisms. Our findings revealed that CTC-TJH-01 cell clusters exhibit resistance to osimertinib, accompanied by activation of the HGF/c-MET pathway and downregulation of EGFR protein expression. Moreover, the c-MET inhibitor Tivantinib, either alone or in combination with osimertinib, effectively suppressed the survival and metastasis of CTC-TJH-01 cell clusters. These results suggest that CTC clusters may mediate resistance to EGFR-TKI treatment, and c-MET inhibitors could be potential therapeutic agents for targeting CTC clusters to inhibit lung cancer metastasis.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Reagents and antibodies</h3>
<p id="Par22">Osimertinib dimesylate (O981804), Tivantinib (T873788) and SRI (S881106) were purchased from Shanghai Macklin Biochemical Technology Co., Ltd (Shanghai, China). Antibodies against EGFR, p-EGFR, HGF, c-MET, p-c-MET, Cleaved caspase-3 and Vimentin were obtained from Affinity Biosciences Pty Ltd (Cincinnati, OH, USA). Ki-67 and Survivin antibodies were procured from Proteintech (Wuhan, China).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par23">The human lung adenocarcinoma circulating tumor cell line CTC-TJH-01 was isolated from the peripheral blood of a female patient with stage IIa lung adenocarcinoma and subsequently established as a stable passaging cell line in our laboratory <sup>[15, 16]</sup>. H1975 and A549 cells were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). For cell cultivation, CTC-TJH-01 cells and A549 cells were cultured in F12K medium supplemented with 10% fetal bovine serum (FBS, Vivacell BIOSCIENCES, Germany) and 1% penicillin-streptomycin solution (Gibco Life Technologies, Carlsbad, CA, USA). H1975 cells were maintained in RPMI-1640 medium containing the same concentration of FBS and penicillin-streptomycin. All cell cultures were incubated at 37 °C in a humidified atmosphere with 5% CO<sub>2</sub>. To establish a CTC suspension culture system for generating cell clusters, ultra-low attachment culture dishes (Corning Cellgro, USA) were employed. Cells were seeded at a density of 1 × 10<sup>5</sup> cells per well in 6 - well ultra-low attachment plates and cultured for 48 h, during which time cell clusters spontaneously formed.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Animals</h3>
<p id="Par24">Twenty-four specific-pathogen-free (SPF) grade, six-week-old male NOD-SCID mice, weighing 18–22 g, were procured from Shanghai Bikai Keyi Biotechnology Co., Ltd. The mice were housed in the SPF-grade animal facility of the Experimental Animal Centre at the Shanghai Tenth People’s Hospital, where the environmental conditions were strictly controlled: room temperature ranged from 20 to 26 °C, humidity was maintained at 40% − 60%, and the animals had free access to autoclaved water and standard rodent chow. All animal experiments were conducted in strict accordance with the regulations of the Experimental Animal Ethics Committee of the Shanghai Tenth People’s Hospital, and the study protocol was approved (Ethics number: SHDSYY-2023-T7885), adhering to the ethical guidelines of the Basel Declaration.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Cell viability analysis</h3>
<p id="Par25">Logarithmically-growing CTC-TJH-01 and A549 cells were seeded into 96-well plates at a density of 3 × 10<sup>3</sup> cells per well. After cell seeding, the cells were treated with various concentrations of osimertinib, Tivantinib, and SRI for 48 h. Subsequently, 10 µL of CCK-8 reagent (Dojindo Molecular Technologies, Inc., Kumamoto, Japan) was added to each well, and the plates were incubated for an additional 2 h. Finally, the absorbance values were measured at 450 nm using a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA), and the cell viability was calculated based on the absorbance data.</p></section><section id="Sec7"><h3 class="pmc_sec_title">LDH cytotoxicity assay</h3>
<p id="Par26">Logarithmically-growing CTC-TJH-01 and A549 cells were seeded into 96-well plates or ultra-low attachment 96-well culture plates. Following cell seeding, the cells were treated with different concentrations of osimertinib, Tivantinib, and SRI for 48 h. Then, 120 µL of the supernatant from each well was carefully transferred to the corresponding well of a new 96-well plate. The LDH assay working solution was freshly prepared according to the manufacturer’s instructions, and 60 µL of the working solution was added to each well of the new plate. After gentle mixing, the plate was incubated at room temperature (approximately 25 °C) in the dark for 30 min. The absorbance was measured at 490 nm using a microplate reader (Bio-Rad Laboratories, Hercules, CA, USA) to quantify the released LDH, which reflects cell membrane damage and cytotoxicity.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Calcein AM/EthD-1 fluorometric detection</h3>
<p id="Par27">Logarithmically-growing CTC-TJH-01 and A549 cells were inoculated into 24-well plates or ultra-low attachment 24-well culture plates. After cell seeding, the cells were treated with various concentrations of osimertinib, Tivantinib, and SRI for 48 h. To assess cell viability and membrane integrity, 1 µL of Calcein AM (500×, CellBiolabs, Inc, USA) and 1 µL of EthD-1 (500×, CellBiolabs, Inc, USA) were added to each well of the 24-well plates. The plates were then incubated at 37 °C for 30–60 min. Subsequently, the cells were observed and imaged using a fluorescence microscope with appropriate excitation and emission filters. Calcein AM stains live cells with green fluorescence, while EthD-1 stains dead cells with red fluorescence, enabling visual assessment of cell viability.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Cell apoptosis assay</h3>
<p id="Par28">CTC-TJH-01 and A549 cells were seeded into the 6-well plate at a density of 1 × 10<sup>5</sup> cells per well. After cell attachment, the cells were treated with osimertinib, Tivantinib, or a combination of osimertinib and tivantinib for 48 h. Following treatment, the cells were harvested, washed twice with cold phosphate - buffered saline (PBS), and stained with Annexin V-PE and caspase 3-FITC (Beyotime Biotechnology, Shanghai, China) according to the manufacturer’s protocols. Briefly, the cells were resuspended in binding buffer, incubated with Annexin V-PE and caspase 3-FITC for 10 min in the dark at room temperature, and then analyzed by flow cytometry (BD FACSCalibur, BD Biosciences, San Jose, CA, USA).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Transcriptomics analysis</h3>
<p id="Par29">Briefly, CTC-TJH-01 cells were collected after adherent and suspension culture, then sent to Sinotech Genomics (Shanghai, China) for RNA sequencing. KEGG signaling pathway enrichment analysis was performed on genes with a fold change greater than 2.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Real-time quantitative real time polymerase chain reaction (qRT-PCR) analysis</h3>
<p id="Par30">Cells were collected, and total RNA was extracted using a total RNA extraction kit (TaKaRa, Japan). RNA concentration was determined, and total RNA was reverse-transcribed into cDNA using RNA reverse transcription reagents according to the manufacturer’s instructions (TaKaRa, Japan). The PCR system was prepared for amplification under the following conditions: predenaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 10 s and annealing/extension at 60 °C for 30 s. Relative mRNA expression was calculated using the 2^(-ΔΔCt) method. Primers were synthesized by Shanghai Generay Biotech Co., Ltd., and their sequences are listed in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Primers used for RT-qPCR analysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Gene</th>
<th align="left" colspan="2" rowspan="1">Primers Sequence</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Forword (5’−3’)</th>
<th align="left" colspan="1" rowspan="1">Reverse (5’−3’)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">EGFR</td>
<td align="left" colspan="1" rowspan="1">AAGAAGACATGGACGACG</td>
<td align="left" colspan="1" rowspan="1">CAGAGGCTGATTGTGATAGAC</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGF</td>
<td align="left" colspan="1" rowspan="1">TGGTAAAGGACGCAGCTACA</td>
<td align="left" colspan="1" rowspan="1">GCGTACCTCTGGATTGCTTG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">c-MET</td>
<td align="left" colspan="1" rowspan="1">CCCACCCTTTGTTCAGTGTG</td>
<td align="left" colspan="1" rowspan="1">AGTCAAGGTGCAGCTCTCAT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GAPDH</td>
<td align="left" colspan="1" rowspan="1">CCCATCACCATCTTCCAG</td>
<td align="left" colspan="1" rowspan="1">CATCACGCCACAGTTTCC</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Western blot analysis</h3>
<p id="Par32">After treating cells with different drugs, the medium was discarded, and cells were washed three times with pre-cooled PBS. Protein lysate was added, and cells were incubated on ice for 15 min. Cells were scraped, collected, and centrifuged at 12,000 rpm for 15 min; the supernatant was harvested for protein quantification. Proteins were separated by SDS-PAGE and transferred to PVDF membranes, which were then blocked at room temperature for 2 h. Membranes were washed three times with PBST (5 min per wash), incubated with the corresponding primary antibodies (1∶1,000) at 4 °C overnight, and then washed again three times with PBST. Horseradish peroxidase (HRP)-conjugated secondary antibody (rabbit IgG) was added, and membranes were incubated at room temperature for 1 h, followed by three additional washes with PBST. Finally, ECL chemiluminescence reagent (Bio-Rad, CA, USA) was applied for development, and images were captured using a chemiluminescence imaging system.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Lung metastasis assays</h3>
<p id="Par33">After digestion and centrifugation, CTC-TJH-01 cells were resuspended and cultured for 24 h. The cell density was adjusted to 1 × 10<sup>6</sup> cells/mL. NOD-SCID mice were allowed a 1-week adaptation period, after which 0.1 ml of the cell suspension was injected via the tail vein to establish the lung cancer metastasis model. Subsequently, the 24 mice were randomly divided into four groups of six mice each. The next day, the mice in each group received intraperitoneal injections of either osimertinib (20 mg/kg/d), tivantinib (2 mg/kg/d), a combination of osimertinib and tivantinib, or an equivalent volume of normal saline. Treatments were administered three times a week for 11 weeks. At the end of the treatment period, the mice were euthanized, and their lungs were harvested. Lung metastatic nodules were visually inspected, counted, and photographed using an anatomical microscope. H&amp;E staining and immunohistochemistry were performed on the lung samples.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Hematoxylin-eosin (H&amp;E) staining</h3>
<p id="Par34">Lung metastasis sections were stained following the instructions of the H&amp;E staining kit. The lung metastatic tissues were first fixed with paraformaldehyde, decalcified with EDTA, dehydrated through a series of gradient-concentration alcohols, and then made transparent with xylene. Subsequently, the tissues were embedded in paraffin and cut into 4-µm-thick paraffin sections. The paraffin sections were deparaffinized with xylene, rehydrated through gradient-concentration alcohols, stained with hematoxylin, and differentiated with hydrochloric acid alcohol. After eosin staining, the sections were dehydrated again with gradient-concentration alcohols, made transparent with xylene, sealed with neutral tree gum, and then observed and photographed under a light microscope.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Immunohistochemistry assays</h3>
<p id="Par35">Paraffin-embedded metastatic tissue specimens were sectioned, and antigen retrieval was performed. The sections were then blocked with BSA and incubated with Vimentin, Ki-67, and cleaved caspase-3 antibodies at 4 °C overnight. After washing, the specimens were incubated with secondary antibodies, stained with 3,3’-Diaminobenzidine (DAB), counterstained with hematoxylin, sealed with neutral mounting medium, and observed under a microscope. The total number of cells and positive-staining cells in each image were counted separately using ImageJ software.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par36">Statistical analyses were conducted using SPSS 23.0 software. All experiments were performed in triplicate (<em>n</em> = 3). Data are presented as the mean ± standard deviation (SD) or the standard error of the mean (SEM). One-way analysis of variance (ANOVA) was used for comparisons among multiple groups. For pairwise comparisons, the Tukey post hoc test was applied when the variances were homogeneous, and Tamhane’s T2 post hoc test was used for data with heterogeneous variances. Statistical significance was set at *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, and ***<em>P</em> &lt; 0.001.</p></section></section><section id="Sec17"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec18"><h3 class="pmc_sec_title">Lung cancer CTC clusters exhibit resistance to osimertinib</h3>
<p id="Par37">Targeted inhibition of CTC cluster survival represents a therapeutic strategy for effectively preventing and treating lung cancer metastasis [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. EGFR-TKIs are effective therapeutic agents for lung cancer patients with EGFR mutations. The CTC-TJH-01 cell line harbors a synonymous single nucleotide variant (Q787Q) in exon 20 of EGFR. We found that adherent single CTC-TJH-01 cells, similar to A549 cells with wild-type EGFR, exhibit higher resistance to osimertinib (Fig. <a href="#Fig1" class="usa-link">1</a>A), with IC<sub>50</sub> values of 5.36 µM and 5.61 µM, respectively (Fig. <a href="#Fig1" class="usa-link">1</a>A). Next, we treated single CTC-TJH-01 cells and suspended CTC-TJH-01 cell clusters with osimertinib at concentrations of 2.5 µM and 5 µM. Osimertinib inhibited the proliferation and survival of both single CTC-TJH-01 cells and CTC-TJH-01 cell clusters (Fig. <a href="#Fig1" class="usa-link">1</a>B-D). Notably, suspended CTC-TJH-01 cell clusters displayed greater resistance to osimertinib compared to single CTC-TJH-01 cells (Fig. <a href="#Fig1" class="usa-link">1</a>B-D). Similar results were observed in human lung adenocarcinoma A549 cells: suspended A549 cell clusters showed reduced sensitivity to osimertinib (Fig. <a href="#MOESM1" class="usa-link">S1</a>). Furthermore, the H1975 cell line—a human non-small cell lung cancer cell line harboring the T790M mutation—was sensitive to osimertinib under adherent culture conditions, but suspended H1975 cell clusters exhibited robust resistance, with IC<sub>50</sub> values of 1.11 µM and 9.94 µM, respectively (Fig. <a href="#MOESM1" class="usa-link">S2</a>). These findings indicate that CTC cluster formation enhances resistance to EGFR-TKI (osimertinib) therapy.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/db88c07b641b/12575_2025_295_Fig1_HTML.jpg" loading="lazy" id="MO2" height="494" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Lung cancer CTC clusters are resistant to osimertinib. <strong>A</strong> Adherent CTC-TJH-01 cells were treated with various concentrations of osimertinib for 48 h, and cell viability was measured using the CCK-8 assay (<em>n</em> = 3). <strong>B</strong> and <strong>C</strong> Adherent and suspended CTC-TJH-01 cells were treated with osimertinib at different concentrations (0, 2.5, 5 µM) for 48 h, and cell viability was measured by CCK-8 and LDH assays (<em>n</em> = 3). <strong>D</strong> Adherent and suspended CTC-TJH-01 cells were treated with osimertinib at different concentrations (0, 2.5, 5 µM) for 48 h, and cell viability was detected by Calcein AM/EthD-1 fluorometric analysis (<em>n</em> = 3). Scale bars, 100 μm. Data are presented as mean ± SD. Statistical significance is denoted as *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec19"><h3 class="pmc_sec_title">Activation of the HGF/c-MET signaling pathway in lung cancer CTC clusters</h3>
<p id="Par39">To investigate the mechanism underlying the enhanced osimertinib resistance of lung cancer CTC clusters, we analyzed transcriptome sequencing data comparing single CTC-TJH-01 cells and CTC-TJH-01 cell clusters. HGF expression was significantly upregulated in CTC-TJH-01 cell clusters (Fig. <a href="#Fig2" class="usa-link">2</a>A). We hypothesized that lung cancer CTC clusters may activate the c-MET signaling pathway via autocrine or paracrine HGF secretion, thereby promoting their survival. We therefore examined the expression of HGF, c-MET, and EGFR at both the mRNA and protein levels in CTC-TJH-01 cell clusters. HGF mRNA was significantly upregulated, while c-MET mRNA remained unchanged (Fig. <a href="#Fig2" class="usa-link">2</a>B). Interestingly, EGFR mRNA was also significantly downregulated in CTC-TJH-01 cell clusters (Fig. <a href="#Fig2" class="usa-link">2</a>B). At the protein level, HGF and phosphorylated c-MET (p-c-MET) were significantly upregulated, whereas EGFR and phosphorylated EGFR (p-EGFR) were significantly downregulated (Fig. <a href="#Fig2" class="usa-link">2</a>C). These results were recapitulated in A549 cell clusters (Fig. S3). Collectively, these data indicate that the EGFR signaling pathway is inactivated in lung cancer CTC clusters, while the HGF/c-MET signaling pathway is activated—likely contributing to their enhanced osimertinib resistance.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/7fb11811c496/12575_2025_295_Fig2_HTML.jpg" loading="lazy" id="MO3" height="452" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Activation of the HGF/c-MET signaling pathway in lung cancer CTC clusters. <strong>A</strong> Transcriptome analysis of differentially expressed genes involved in the focal adhesion pathway in CTC-TJH-01 cells cultured under adherent and suspension conditions. <strong>B</strong> and <strong>C</strong> Expression levels of EGFR, HGF, and c-MET mRNA and protein in CTC-TJH-01 cells under adherent and suspension culture conditions were analyzed by RT-qPCR and western blot (<em>n</em> = 3). Data are presented as mean ± SD. Statistical significance is denoted as *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec20"><h3 class="pmc_sec_title">Tivantinib, a c-MET inhibitor, but not the HGF inhibitor SRI, effectively suppresses the survival of lung cancer CTC clusters</h3>
<p id="Par41">Given the activation of the HGF/c-MET pathway in lung cancer CTC clusters, we hypothesized that inhibitors of this pathway may effectively eliminate CTC clusters. We therefore treated CTC-TJH-01 cell clusters with the HGF inhibitor SRI or the c-MET inhibitor tivantinib. Tivantinib inhibited CTC-TJH-01 cell proliferation in a dose-dependent manner (Fig. <a href="#Fig3" class="usa-link">3</a>A), whereas SRI had no inhibitory effect (Fig. <a href="#Fig3" class="usa-link">3</a>D). Compared to osimertinib, tivantinib at 0.5 µM and 1 µM significantly inhibited the survival of both single CTC-TJH-01 cells and CTC-TJH-01 cell clusters, with clusters exhibiting greater sensitivity to tivantinib (Fig. <a href="#Fig3" class="usa-link">3</a>B-C). In contrast, SRI had no significant effect on the survival of CTC-TJH-01 cells or clusters (Fig. <a href="#Fig3" class="usa-link">3</a>E-F). Similar results were observed in A549 cells: A549 clusters were more sensitive to tivantinib, while SRI had no effect on A549 cell or cluster proliferation/survival (Fig. S4). In addition, western blot analysis revealed that tivantinib significantly downregulated the protein expression of p-c-MET in CTC-TJH-01 cell clusters, whereas SRI had no significant effect (Fig. S5). These findings demonstrate that the c-MET inhibitor tivantinib, but not the HGF inhibitor SRI, exerts significant cytotoxic effects on lung cancer CTC clusters.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/13750572c3b0/12575_2025_295_Fig3_HTML.jpg" loading="lazy" id="MO4" height="1107" width="744" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The c-MET inhibitor tivantinib, but not the HGF inhibitor SRI, effectively suppresses the survival of lung cancer CTC clusters. <strong>A</strong> and <strong>D</strong> Adherent CTC-TJH-01 cells were treated with various concentrations of tivantinib and SRI for 48 h, and cell viability was measured using the CCK-8 assay (<em>n</em> = 3). <strong>B</strong> and <strong>E</strong> Adherent and suspended CTC-TJH-01 cells were treated with tivantinib (0, 0.5, 1 µM) and SRI (0, 2.5, 5 µM) for 48 h, and cell viability was measured by LDH assay (<em>n</em> = 3). <strong>C</strong> and <strong>F</strong> Adherent and suspended CTC-TJH-01 cells were treated with tivantinib (0, 0.5, 1 µM) and SRI (0, 2.5, 5 µM) for 48 h, followed by detection of cell apoptosis via Calcein AM/EthD-1 fluorometric analysis (<em>n</em> = 3). Scale bars, 100 μm. Data are presented as mean ± SD. Statistical significance is denoted as *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">Tivantinib enhances the ability of osimertinib to restrain lung cancer CTC cluster survival</h3>
<p id="Par43">Bypass pathway activation, such as the HGF/c-MET pathway, is a known mechanism of EGFR-TKI resistance in lung cancer [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Given the activation of HGF/c-MET signaling in lung cancer CTC clusters, we investigated whether combined EGFR and c-MET inhibition could more effectively suppress CTC cluster survival. We treated CTC-TJH-01 cell clusters with tivantinib in combination with osimertinib. Both 5 µM osimertinib and 0.5 µM tivantinib significantly inhibited CTC-TJH-01 cluster survival (Fig. <a href="#Fig4" class="usa-link">4</a>A-C) and upregulated cleaved caspase-3 expression while downregulating Survivin expression (Fig. <a href="#Fig4" class="usa-link">4</a>D). Notably, the combination of tivantinib and osimertinib exerted a stronger inhibitory effect on CTC-TJH-01 cluster survival (Fig. <a href="#Fig4" class="usa-link">4</a>A-D). These results were confirmed in A549 cell clusters (Fig. S6), indicating that tivantinib enhances the ability of osimertinib to suppress lung cancer CTC cluster survival.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/98c011959f2d/12575_2025_295_Fig4_HTML.jpg" loading="lazy" id="d33e782" height="700" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Tivantinib enhances the ability of osimertinib to restrain the survival of lung cancer CTC clusters. <strong>A</strong> Cell viability was measured by LDH assay (<em>n</em> = 3) using 5 µM osimertinib and 0.5 µM tivantinib. <strong>B</strong> Cell apoptosis was detected by Calcein AM/EthD-1 fluorometric detection (<em>n</em> = 3) using 5 µM osimertinib and 0.5 µM tivantinib. Scale bars, 100 μm. <strong>C</strong> Cell apoptosis was measured by Annexin V-FITC/caspase-3 assay (<em>n</em> = 3) using 5 µM osimertinib and 0.5 µM tivantinib. <strong>D</strong> Protein expression levels of cleaved caspase-3 and survivin in CTC-TJH-01 clusters were determined by western blotting (<em>n</em> = 3) using 5 µM osimertinib and 0.5 µM tivantinib. Data are presented as mean ± SD. Statistical significance is denoted as *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001</p></figcaption></figure></section><section id="Sec22"><h3 class="pmc_sec_title">Tivantinib enhances the inhibitory effect of osimertinib on lung cancer CTC cluster metastasis</h3>
<p id="Par45">To further explore whether tivantinib combined with osimertinib inhibits lung cancer metastasis by suppressing CTC cluster survival, we established a lung metastasis model via tail vein injection of CTC-TJH-01 cell clusters into NOD/SCID mice. Both tivantinib and osimertinib significantly reduced the number of lung metastatic nodules, with the combination treatment yielding the greatest reduction (Fig. <a href="#Fig5" class="usa-link">5</a>A). Neither treatment affected mouse body weight (Fig. <a href="#Fig5" class="usa-link">5</a>B). Lung metastasis burden was also significantly reduced in the tivantinib, osimertinib, and combination groups (Fig. <a href="#Fig5" class="usa-link">5</a>C). In metastatic tumor tissues, Ki-67 and vimentin expression were significantly downregulated, while cleaved caspase-3 expression was significantly upregulated in all treatment groups (Fig. <a href="#Fig5" class="usa-link">5</a>D). Taken together, these results demonstrate that tivantinib effectively suppresses lung cancer CTC cluster metastasis and enhances the antimetastatic effect of osimertinib when used in combination.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366314_12575_2025_295_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da5/12366314/7e4c4e91a7b4/12575_2025_295_Fig5_HTML.jpg" loading="lazy" id="MO6" height="589" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Tivantinib enhances the inhibitory effect of osimertinib on metastasis of lung cancer CTC clusters. <strong>A</strong> A lung metastasis model was established by tail vein injection of CTC-TJH-01 cell clusters into NOD-SCID mice. Mice were treated with osimertinib (20 mg/kg), tivantinib (2 mg/kg), or their combination via intraperitoneal injection for 11 weeks. Representative lung images and quantification of pulmonary metastatic nodules in each group (<em>n</em> = 6). <strong>B</strong> Body weights of NOD-SCID mice. <strong>C</strong> H&amp;E staining was performed to observe the morphology of pulmonary metastatic nodules (0.5×, 4×, 20×) (<em>n</em> = 3). <strong>D</strong> Immunohistochemistry was used to detect the expression of vimentin, Ki-67, and cleaved caspase-3 in pulmonary metastatic nodules (<em>n</em> = 3). Scale bars, 100 μm. Data are presented as mean ± SD. Statistical significance is denoted as *<em>P</em> &lt; 0.05, **<em>P</em> &lt; 0.01, ***<em>P</em> &lt; 0.001</p></figcaption></figure></section></section><section id="Sec23"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par47">In this study, we investigated the role of lung cancer CTC clusters in acquired resistance to EGFR-TKIs. Our findings demonstrate that the HGF/c-MET signaling pathway is activated in lung cancer CTC clusters, contributing to osimertinib resistance. Additionally, the c-MET inhibitor tivantinib enhances the efficacy of osimertinib, effectively suppressing the survival and metastasis of lung cancer CTC clusters. These results provide a novel therapeutic strategy for lung cancer patients with detectable CTC clusters and high metastatic risk.</p>
<p id="Par48">CTCs, often referred to as the “seeds” of tumor metastasis, are widely used as biomarkers for assessing metastatic risk, monitoring treatment efficacy, evaluating prognosis, and guiding therapy in early postoperative lung cancer patients [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Accumulating evidence indicates that CTC clusters exhibit higher metastatic potential than single CTCs [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>], and patients with detectable CTC clusters in peripheral blood have shorter DFS and OS [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. This may be attributed to the quiescent state of CTC clusters, their cancer stem cell-like properties, and intrinsic drug resistance [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. For example, Dashzeveg et al. found that breast cancer CTC clusters are quiescent and resistant to chemotherapy [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], prompting efforts to prevent metastasis by dissociating CTC clusters into single cells [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. In our study, we utilized the human lung adenocarcinoma CTC line CTC-TJH-01, which harbors a synonymous single nucleotide variant (Q787Q) in exon 20 of EGFR [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. We also incorporated A549 (EGFR WT) and H1975 (EGFR L858R/T790M mutant) cells to examine whether osimertinib resistance in CTC clusters is contingent upon EGFR mutation status. We noted that both A549 cells (intrinsically resistant) and H1975 cells (initially sensitive) exhibited enhanced resistance when clustered. These findings indicate that CTC cluster-mediated osimertinib resistance is independent of EGFR genotype, likely through a universal adaptive mechanism. These results may partially account for the reduced survival and poorer prognosis observed in patients with detectable CTC clusters [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par49">CTC clusters evade anoikis by activating survival pathways [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Bypass pathway activation is a critical mechanism of acquired osimertinib resistance, including PI3K/AKT/mTOR pathway activation due to MET or HER2 amplification [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. We therefore compared adherent single CTC-TJH-01 cells with suspended CTC-TJH-01 clusters, finding that HGF mRNA and protein expression were significantly upregulated in clusters, while EGFR mRNA and protein were significantly downregulated. These data suggest that lung cancer CTC clusters may activate c-MET signaling via autocrine or paracrine HGF secretion, driving osimertinib resistance. Additionally, EGFR pathway inactivation likely reduces cluster sensitivity to osimertinib.</p>
<p id="Par50">MET amplification and overexpression are key mechanisms of acquired osimertinib resistance [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>], occurring in 15–20% of NSCLC patients with osimertinib resistance [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Studies have confirmed that MET inhibitors improve survival in NSCLC patients with MET amplification or overexpression [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>], and combining MET inhibitors with EGFR-TKIs can overcome resistance by co-targeting EGFR and MET signaling [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. In our experiments, the HGF inhibitor SRI had no effect on lung cancer CTC cluster proliferation or survival, whereas the c-MET inhibitor tivantinib markedly suppressed cluster survival. The lack of efficacy of the HGF inhibitor SRI in CTC-TJH-01 cells likely arises from its mechanism of action: SRI primarily blocks HGF-mediated c-MET activation but does not directly inhibit ligand-independent c-MET signaling or downstream pathway activity. In contrast, Tivantinib, as a direct c-MET kinase inhibitor, more effectively reduces p-c-MET levels regardless of HGF stimulation, which aligns with its observed anti-proliferative effects [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. This suggests that lung cancer CTC clusters are more sensitive to c-MET inhibition. Consistent with this, Yap et al. reported that the c-MET inhibitor ARQ 197 reduces CTC counts in the peripheral blood of lung cancer patients [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Furthermore, we found that tivantinib enhanced osimertinib-mediated inhibition of CTC cluster survival and significantly reduced the metastatic potential of clusters in mice, with concomitant upregulation of cleaved caspase-3 in both CTC clusters and metastatic tumor tissues.</p></section><section id="Sec24"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par51">In conclusion, our study demonstrates that lung cancer CTC clusters exhibit resistance to osimertinib. Mechanistically, the HGF/c-MET signaling pathway is activated in lung cancer CTC clusters, accompanied by downregulated EGFR protein expression. Notably, our findings reveal that the c-MET inhibitor tivantinib—rather than the HGF inhibitor SRI—plays a critical role in suppressing the survival of lung cancer CTC clusters. Furthermore, tivantinib enhances the ability of osimertinib to inhibit the survival and metastasis of lung cancer CTC clusters. These results highlight tivantinib as a promising therapeutic agent for combating metastasis driven by lung cancer CTC clusters.</p></section><section id="Sec25"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366314/bin/12575_2025_295_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (1.9MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>CTCs</dt>
<dd><p id="Par10">Circulating tumor cells</p></dd>
<dt>DFS</dt>
<dd><p id="Par11">Disease-free survival</p></dd>
<dt>OS</dt>
<dd><p id="Par12">Overall survival</p></dd>
<dt>NSCLC</dt>
<dd><p id="Par13">Non-small cell lung cancer</p></dd>
<dt>EGFR-TKIs</dt>
<dd><p id="Par14">Epidermal growth factor receptor-tyrosine kinase inhibitors</p></dd>
<dt>PFS</dt>
<dd><p id="Par15">Progression-free survival</p></dd>
<dt>qRT-PCR</dt>
<dd><p id="Par16">Quantitative real-time polymerase chain reaction</p></dd>
<dt>H&amp;E</dt>
<dd><p id="Par17">Hematoxylin and eosin</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Authors' contributions</h2>
<p>Zhang. Z., Lu. X. drafted the manuscript. Li. J., Liu. S., Liu. J. conducted the experimental verification. Luo. Bi., Yao. J., Liu. Y. contributed to the animal experiment. Wang. Y., Yao. W., Yang. Y., Shangguan. W. assisted in conceptualization. Que. Z. supervised and revised the manuscript. Tian. J. administrated funding and revised the manuscript. All the authors contributed to the study and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was supported by National Natural Science Foundation of China (82174245, 82174017, 82404913), Shanghai Frontier Research Base of Disease and Syndrome Biology of Inflammatory Cancer Transformation (2021KJ03-12), Shanghai Municipal Health Leading Talents Program (2022LJ014).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par52">All animal experiments followed the regulations of the Experimental Animal Ethics Committee of Shanghai Tenth People’s Hospital and approved (Ethics number: SHDSYY-2023-T7885).</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par53">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par54">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Zhipeng Zhang and Xinyi Lu contributed equally as the first authors to this work.</p></div>
<div class="fn p" id="fn3"><p>Jianhui Tian and Zujun Que contributed equally as corresponding authors to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Jianhui Tian, Email: tjhhawk@163.com.</p>
<p>Zujun Que, Email: zujunque@shutcm.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray%20F,%20Laversanne%20M,%20Sung%20H,%20Ferlay%20J,%20Siegel%20RL,%20Soerjomataram%20I,%20et%20al.%20Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J%20Clin.%202024;74(3):229%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Gerstberger S, Jiang Q, Ganesh K. Metastasis Cell. 2023;186(8):1564–79.
</cite> [<a href="https://doi.org/10.1016/j.cell.2023.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10511214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37059065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gerstberger%20S,%20Jiang%20Q,%20Ganesh%20K.%20Metastasis%20Cell.%202023;186(8):1564%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, et al. Overall survival with osimertinib in resected EGFR-mutated NSCLC. N Engl J Med. 2023;389(2):137–47.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2304594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37272535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsuboi%20M,%20Herbst%20RS,%20John%20T,%20Kato%20T,%20Majem%20M,%20Groh%C3%A9%20C,%20et%20al.%20Overall%20survival%20with%20osimertinib%20in%20resected%20EGFR-mutated%20NSCLC.%20N%20Engl%20J%20Med.%202023;389(2):137%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Provencio M, Nadal E, Gonzalez-Larriba JL, Martínez-Martí A, Bernabé R, Bosch-Barrera J, et al. Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2023;389(6):504–13.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2215530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37379158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Provencio%20M,%20Nadal%20E,%20Gonzalez-Larriba%20JL,%20Mart%C3%ADnez-Mart%C3%AD%20A,%20Bernab%C3%A9%20R,%20Bosch-Barrera%20J,%20et%20al.%20Perioperative%20nivolumab%20and%20chemotherapy%20in%20stage%20III%20non-small-cell%20lung%20cancer.%20N%20Engl%20J%20Med.%202023;389(6):504%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant navelbine international trialist association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7(9):719–27.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(06)70804-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16945766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Douillard%20JY,%20Rosell%20R,%20De%20Lena%20M,%20Carpagnano%20F,%20Ramlau%20R,%20Gonz%C3%A1les-Larriba%20JL,%20et%20al.%20Adjuvant%20vinorelbine%20plus%20cisplatin%20versus%20observation%20in%20patients%20with%20completely%20resected%20stage%20IB-IIIA%20non-small-cell%20lung%20cancer%20(Adjuvant%20navelbine%20international%20trialist%20association%20%5BANITA%5D):%20a%20randomised%20controlled%20trial.%20Lancet%20Oncol.%202006;7(9):719%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Planchard D, Janne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, et al. Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N Engl J Med. 2023;389(21):1935–48.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2306434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37937763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Planchard%20D,%20Janne%20PA,%20Cheng%20Y,%20Yang%20JC,%20Yanagitani%20N,%20Kim%20SW,%20et%20al.%20Osimertinib%20with%20or%20without%20chemotherapy%20in%20EGFR-mutated%20advanced%20NSCLC.%20N%20Engl%20J%20Med.%202023;389(21):1935%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Chmielecki J, Gray JE, Cheng Y, Ohe Y, Imamura F, Cho BC, et al. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nat Commun. 2023;14(1):1070.
</cite> [<a href="https://doi.org/10.1038/s41467-023-35961-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9971254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36849494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chmielecki%20J,%20Gray%20JE,%20Cheng%20Y,%20Ohe%20Y,%20Imamura%20F,%20Cho%20BC,%20et%20al.%20Candidate%20mechanisms%20of%20acquired%20resistance%20to%20first-line%20osimertinib%20in%20EGFR-mutated%20advanced%20non-small%20cell%20lung%20cancer.%20Nat%20Commun.%202023;14(1):1070." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Hartmaier RJ, Markovets AA, Ahn MJ, Sequist LV, Han JY, Cho BC, et al. Osimertinib + Savolitinib to overcome acquired MET-Mediated resistance in epidermal growth factor receptor-Mutated, MET-Amplified non-small cell lung cancer: TATTON. Cancer Discov. 2023;13(1):98–113.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-22-0586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9827108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36264123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hartmaier%20RJ,%20Markovets%20AA,%20Ahn%20MJ,%20Sequist%20LV,%20Han%20JY,%20Cho%20BC,%20et%20al.%20Osimertinib%E2%80%89+%E2%80%89Savolitinib%20to%20overcome%20acquired%20MET-Mediated%20resistance%20in%20epidermal%20growth%20factor%20receptor-Mutated,%20MET-Amplified%20non-small%20cell%20lung%20cancer:%20TATTON.%20Cancer%20Discov.%202023;13(1):98%E2%80%93113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Wang Y, Liu Y, Zhang Z, Lu B, Gao Y, Tong L, et al. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer. BMC Cancer. 2023;23(1): 578.
</cite> [<a href="https://doi.org/10.1186/s12885-023-10985-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10286386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37349714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Liu%20Y,%20Zhang%20Z,%20Lu%20B,%20Gao%20Y,%20Tong%20L,%20et%20al.%20Post-therapeutic%20circulating%20tumor%20cell-associated%20white%20blood%20cell%20clusters%20predict%20poor%20survival%20in%20patients%20with%20advanced%20driver%20gene-negative%20non-small%20cell%20lung%20cancer.%20BMC%20Cancer.%202023;23(1):%20578." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Xu Y, Ren X, Jiang T, Lv S, Gao K, Liu Y, et al. Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer. BMC Cancer. 2023;23(1):475.
</cite> [<a href="https://doi.org/10.1186/s12885-023-10979-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10207832/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37226235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Y,%20Ren%20X,%20Jiang%20T,%20Lv%20S,%20Gao%20K,%20Liu%20Y,%20et%20al.%20Circulating%20tumor%20cells%20(CTCs)%20and%20hTERT%20gene%20expression%20in%20CTCs%20for%20radiotherapy%20effect%20with%20lung%20cancer.%20BMC%20Cancer.%202023;23(1):475." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Liu X, Taftaf R, Kawaguchi M, Chang YF, Chen W, Entenberg D, et al. Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models. Cancer Discov. 2019;9(1):96–113.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-18-0065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6328322/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30361447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Taftaf%20R,%20Kawaguchi%20M,%20Chang%20YF,%20Chen%20W,%20Entenberg%20D,%20et%20al.%20Homophilic%20CD44%20interactions%20mediate%20tumor%20cell%20aggregation%20and%20polyclonal%20metastasis%20in%20patient-derived%20breast%20cancer%20models.%20Cancer%20Discov.%202019;9(1):96%E2%80%93113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Dashzeveg NK, Jia Y, Zhang Y, Gerratana L, Patel P, Shajahan A, et al. Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer. Cancer Discov. 2023;13(9):2050–71.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-22-0644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10481132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37272843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dashzeveg%20NK,%20Jia%20Y,%20Zhang%20Y,%20Gerratana%20L,%20Patel%20P,%20Shajahan%20A,%20et%20al.%20Dynamic%20glycoprotein%20hyposialylation%20promotes%20chemotherapy%20evasion%20and%20metastatic%20seeding%20of%20quiescent%20circulating%20tumor%20cell%20clusters%20in%20breast%20cancer.%20Cancer%20Discov.%202023;13(9):2050%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, Scherrer R, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176(1–2):98–e11214.
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.11.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6363966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30633912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gkountela%20S,%20Castro-Giner%20F,%20Szczerba%20BM,%20Vetter%20M,%20Landin%20J,%20Scherrer%20R,%20et%20al.%20Circulating%20tumor%20cell%20clustering%20shapes%20DNA%20methylation%20to%20enable%20metastasis%20seeding.%20Cell.%202019;176(1%E2%80%932):98%E2%80%93e11214." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Lim M, Park J, Lowe AC, Jeong HO, Lee S, Park HC, et al. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC. Theranostics. 2020;10(12):5181–94.
</cite> [<a href="https://doi.org/10.7150/thno.44693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7196290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32373206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20M,%20Park%20J,%20Lowe%20AC,%20Jeong%20HO,%20Lee%20S,%20Park%20HC,%20et%20al.%20A%20lab-on-a-disc%20platform%20enables%20serial%20monitoring%20of%20individual%20CTCs%20associated%20with%20tumor%20progression%20during%20EGFR-targeted%20therapy%20for%20patients%20with%20NSCLC.%20Theranostics.%202020;10(12):5181%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Wang ZH, Wu WJ, Wang Z, Tang Y, Deng Y, Xu L, et al. Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation. Analyst. 2016;141(12):3621–5.
</cite> [<a href="https://doi.org/10.1039/c5an02554k" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26887792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20ZH,%20Wu%20WJ,%20Wang%20Z,%20Tang%20Y,%20Deng%20Y,%20Xu%20L,%20et%20al.%20Ex%20vivo%20expansion%20of%20circulating%20lung%20tumor%20cells%20based%20on%20one-step%20microfluidics-based%20immunomagnetic%20isolation.%20Analyst.%202016;141(12):3621%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Que ZJ, Luo B, Zhou ZY, Dong C, Jiang Y, Wang L, et al. Establishment and characterization of a patient-derived circulating lung tumor cell line <em>in vitro</em> and <em>in vivo</em>. Cancer Cell Int. 2019;19: 21.
</cite> [<a href="https://doi.org/10.1186/s12935-019-0735-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6352330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30718976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Que%20ZJ,%20Luo%20B,%20Zhou%20ZY,%20Dong%20C,%20Jiang%20Y,%20Wang%20L,%20et%20al.%20Establishment%20and%20characterization%20of%20a%20patient-derived%20circulating%20lung%20tumor%20cell%20line%20in%20vitro%20and%20in%20vivo.%20Cancer%20Cell%20Int.%202019;19:%2021." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Ring A, Nguyen-Strauli BD, Wicki A, Aceto N. Biology, vulnerabilities and clinical applications of circulating tumour cells. Nat Rev Cancer. 2023;23(2):95–111.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00536-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9734934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36494603/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ring%20A,%20Nguyen-Strauli%20BD,%20Wicki%20A,%20Aceto%20N.%20Biology,%20vulnerabilities%20and%20clinical%20applications%20of%20circulating%20tumour%20cells.%20Nat%20Rev%20Cancer.%202023;23(2):95%E2%80%93111." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wang Q, Yang S, Wang K, Sun SY. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer. J Hematol Oncol. 2019;12(1):63.
</cite> [<a href="https://doi.org/10.1186/s13045-019-0759-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6588884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31227004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Q,%20Yang%20S,%20Wang%20K,%20Sun%20SY.%20MET%20inhibitors%20for%20targeted%20therapy%20of%20EGFR%20TKI-resistant%20lung%20cancer.%20J%20Hematol%20Oncol.%202019;12(1):63." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110–22.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4149753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25171411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aceto%20N,%20Bardia%20A,%20Miyamoto%20DT,%20Donaldson%20MC,%20Wittner%20BS,%20Spencer%20JA,%20et%20al.%20Circulating%20tumor%20cell%20clusters%20are%20oligoclonal%20precursors%20of%20breast%20cancer%20metastasis.%20Cell.%202014;158(5):1110%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Que Z, Xi Z, Qi D, Dai R, Li Y, Liu M, et al. Src/FN1 pathway activation drives tumor cell cluster formation and metastasis in lung cancer: a promising therapeutic target. Sci Adv. 2025;11(28): eadv7377.
</cite> [<a href="https://doi.org/10.1126/sciadv.adv7377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12239954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40632865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Que%20Z,%20Xi%20Z,%20Qi%20D,%20Dai%20R,%20Li%20Y,%20Liu%20M,%20et%20al.%20Src/FN1%20pathway%20activation%20drives%20tumor%20cell%20cluster%20formation%20and%20metastasis%20in%20lung%20cancer:%20a%20promising%20therapeutic%20target.%20Sci%20Adv.%202025;11(28):%20eadv7377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Manjunath Y, Upparahalli SV, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O’Carroll KF, et al. Circulating tumor cell clusters are a potential biomarker for detection of non-small cell lung cancer. Lung Cancer. 2019;134:147–50.
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2019.06.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31319973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Manjunath%20Y,%20Upparahalli%20SV,%20Suvilesh%20KN,%20Avella%20DM,%20Kimchi%20ET,%20Staveley-O%E2%80%99Carroll%20KF,%20et%20al.%20Circulating%20tumor%20cell%20clusters%20are%20a%20potential%20biomarker%20for%20detection%20of%20non-small%20cell%20lung%20cancer.%20Lung%20Cancer.%202019;134:147%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zhao L, Song J, Sun Y, Ju Q, Mu H, Dong X, et al. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients. Cancer Med. 2023;12(13):13912–27.
</cite> [<a href="https://doi.org/10.1002/cam4.5946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10358265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37337648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20L,%20Song%20J,%20Sun%20Y,%20Ju%20Q,%20Mu%20H,%20Dong%20X,%20et%20al.%20Tumor-derived%20proliferative%20CTCs%20and%20CTC%20clusters%20predict%20aggressiveness%20and%20early%20recurrence%20in%20hepatocellular%20carcinoma%20patients.%20Cancer%20Med.%202023;12(13):13912%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Que Z, Qi D, Yang Y, Yao W, Liu J, Li Y, et al. Regulating chemoresistance and cancer stemness: the CDH17-YAP pathway in distinct cellular states of lung cancer CTC clusters. Cell Mol Biol Lett. 2025;30(1):23.
</cite> [<a href="https://doi.org/10.1186/s11658-025-00696-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11849222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39994505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Que%20Z,%20Qi%20D,%20Yang%20Y,%20Yao%20W,%20Liu%20J,%20Li%20Y,%20et%20al.%20Regulating%20chemoresistance%20and%20cancer%20stemness:%20the%20CDH17-YAP%20pathway%20in%20distinct%20cellular%20states%20of%20lung%20cancer%20CTC%20clusters.%20Cell%20Mol%20Biol%20Lett.%202025;30(1):23." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Maeshiro M, Shinriki S, Liu R, Nakachi Y, Komohara Y, Fujiwara Y, et al. Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress. Sci Rep. 2021;11(1):6150.
</cite> [<a href="https://doi.org/10.1038/s41598-021-85743-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7969766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33731803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maeshiro%20M,%20Shinriki%20S,%20Liu%20R,%20Nakachi%20Y,%20Komohara%20Y,%20Fujiwara%20Y,%20et%20al.%20Colonization%20of%20distant%20organs%20by%20tumor%20cells%20generating%20circulating%20homotypic%20clusters%20adaptive%20to%20fluid%20shear%20stress.%20Sci%20Rep.%202021;11(1):6150." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer. 2019;121(9):725–37.
</cite> [<a href="https://doi.org/10.1038/s41416-019-0573-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6889286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31564718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leonetti%20A,%20Sharma%20S,%20Minari%20R,%20Perego%20P,%20Giovannetti%20E,%20Tiseo%20M.%20Resistance%20mechanisms%20to%20osimertinib%20in%20EGFR-mutated%20non-small%20cell%20lung%20cancer.%20Br%20J%20Cancer.%202019;121(9):725%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Murtuza A, Bulbul A, Shen JP, Keshavarzian P, Woodward BD, Lopez-Diaz FJ, et al. Novel third-generation EGFR tyrosine kinase inhibitors and strategies to overcome therapeutic resistance in lung cancer. Cancer Res. 2019;79(4):689–98.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-18-1281" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30718357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murtuza%20A,%20Bulbul%20A,%20Shen%20JP,%20Keshavarzian%20P,%20Woodward%20BD,%20Lopez-Diaz%20FJ,%20et%20al.%20Novel%20third-generation%20EGFR%20tyrosine%20kinase%20inhibitors%20and%20strategies%20to%20overcome%20therapeutic%20resistance%20in%20lung%20cancer.%20Cancer%20Res.%202019;79(4):689%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Shah MP, Neal JW. Targeting acquired and intrinsic resistance mechanisms in epidermal growth factor receptor mutant Non-Small-Cell. Lung Cancer. 2022;82(6):649–62.</cite> [<a href="https://doi.org/10.1007/s40265-022-01698-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35412115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shah%20MP,%20Neal%20JW.%20Targeting%20acquired%20and%20intrinsic%20resistance%20mechanisms%20in%20epidermal%20growth%20factor%20receptor%20mutant%20Non-Small-Cell.%20Lung%20Cancer.%202022;82(6):649%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Remon J, Hendriks LEL, Mountzios G, García-Campelo R, Saw SPL, Uprety D, et al. MET alterations in NSCLC-current perspectives and future challenges. J Thorac Oncol. 2023;18(4):419–35.
</cite> [<a href="https://doi.org/10.1016/j.jtho.2022.10.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36441095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Remon%20J,%20Hendriks%20LEL,%20Mountzios%20G,%20Garc%C3%ADa-Campelo%20R,%20Saw%20SPL,%20Uprety%20D,%20et%20al.%20MET%20alterations%20in%20NSCLC-current%20perspectives%20and%20future%20challenges.%20J%20Thorac%20Oncol.%202023;18(4):419%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Wu YL, Guarneri V, Voon PJ, Lim BK, Yang JJ, Wislez M, et al. Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial. Lancet Oncol. 2024;25(8):989–1002.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(24)00270-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39089305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20YL,%20Guarneri%20V,%20Voon%20PJ,%20Lim%20BK,%20Yang%20JJ,%20Wislez%20M,%20et%20al.%20Tepotinib%20plus%20osimertinib%20in%20patients%20with%20EGFR-mutated%20non-small-cell%20lung%20cancer%20with%20MET%20amplification%20following%20progression%20on%20first-line%20osimertinib%20(INSIGHT%202):%20a%20multicentre,%20open-label,%20phase%202%20trial.%20Lancet%20Oncol.%202024;25(8):989%E2%80%931002." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Qu G, Liu C, Sun B, Zhou C, Zhang Z, Wang P. Combination of BIBW2992 and ARQ 197 is effective against erlotinib-resistant human lung cancer cells with the EGFR T790M mutation. Oncol Rep. 2014;32(1):341–7.
</cite> [<a href="https://doi.org/10.3892/or.2014.3178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24842595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qu%20G,%20Liu%20C,%20Sun%20B,%20Zhou%20C,%20Zhang%20Z,%20Wang%20P.%20Combination%20of%20BIBW2992%20and%20ARQ%20197%20is%20effective%20against%20erlotinib-resistant%20human%20lung%20cancer%20cells%20with%20the%20EGFR%20T790M%20mutation.%20Oncol%20Rep.%202014;32(1):341%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Pasquini G, Giaccone G. C-MET inhibitors for advanced non-small cell lung cancer. Expert Opin Investig Drugs. 2018;27(4):363–75.
</cite> [<a href="https://doi.org/10.1080/13543784.2018.1462336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29621416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pasquini%20G,%20Giaccone%20G.%20C-MET%20inhibitors%20for%20advanced%20non-small%20cell%20lung%20cancer.%20Expert%20Opin%20Investig%20Drugs.%202018;27(4):363%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Yap TA, Olmos D, Brunetto AT, Tunariu N, Barriuso J, Riisnaes R, et al. Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. J Clin Oncol. 2011;29(10):1271–9.
</cite> [<a href="https://doi.org/10.1200/JCO.2010.31.0367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21383285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yap%20TA,%20Olmos%20D,%20Brunetto%20AT,%20Tunariu%20N,%20Barriuso%20J,%20Riisnaes%20R,%20et%20al.%20Phase%20I%20trial%20of%20a%20selective%20c-MET%20inhibitor%20ARQ%20197%20incorporating%20proof%20of%20mechanism%20pharmacodynamic%20studies.%20J%20Clin%20Oncol.%202011;29(10):1271%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366314/bin/12575_2025_295_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (1.9MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Biological Procedures Online are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12575-025-00295-0"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12575_2025_Article_295.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366314/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366314/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366314%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366314/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366314/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366314/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40836278/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366314/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40836278/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366314/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366314/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="dmP9fH8BgUvqdHjjyG6hv6mHv0pnQbfnaVXBTNblBX3OhsNMB0JBd7CIkx6nCDd9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
